Izencitinib induction treatment in patients with moderately-to-severely-active Crohn's Disease: A phase 2 double-blind, randomized, placebo-controlled study

被引：0
|
作者：
Schreiber, S. [1 ]
Reinisch, W. [2 ]
Nguyen, D. [3 ]
Guerin, T. [4 ]
Kierkus, J. [5 ]
Rozpondek, P. [6 ]
Bourdet, D. [3 ]
Abhyankar, B. [7 ]
Peyrin-Biroulet, L. [8 ]
机构：
[1] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Internal Med I, Kiel, Germany
[2] Med Univ Vienna, Dept Internal Med III, Vienna, Austria
[3] Theravance Biopharma Inc, Res & Dev, San Francisco, CA USA
[4] Theravance Biopharma Ireland Ltd, Res & Dev, Dublin, Ireland
[5] Childrens Mem Hlth Inst, Dept Gastroenterol, Warsaw, Poland
[6] Krakow Med Ctr, Krakow, Poland
[7] Theravance Biopharma Ireland Ltd, Clin Dev, Dublin, Ireland
[8] Univ Lorraine, Nancy Univ Hosp, Dept Gastroenterol, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P375
引用
收藏
页码：505 / 507
页数：3
相关论文
共 50 条
  • [41] A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
    Howard, Joanna
    Kuo, Kevin H. M.
    Oluyadi, Abdulafeez
    Shao, Hui
    Morris, Susan
    Zaidi, Ahmar U.
    Van Beers, Eduard J.
    Thien, Swee Lay
    BLOOD, 2021, 138
  • [42] Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study
    Isaacs, Kim L.
    Sandler, Robert S.
    Abreu, Maria
    Picco, Michael F.
    Hanauer, Stephen B.
    Bickston, Stephen J.
    Present, Daniel
    Farraye, Francis A.
    Wolf, Douglas
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (10) : 1250 - 1255
  • [43] Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study
    Jorgensen, S. P.
    Agnholt, J.
    Glerup, H.
    Lyhne, S.
    Villadsen, G. E.
    Hvas, C. L.
    Bartels, L. E.
    Kelsen, J.
    Christensen, L. A.
    Dahlerup, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) : 377 - 383
  • [44] Budesonide As Induction Treatment For Active Eosinophilic Esophagitis In Adolescents And Adults: A Randomized, Double-blind, Placebo-controlled Study
    Straumann, A.
    Degen, L.
    Felder, S.
    Bussmann, C.
    Conus, S.
    Thalmann, C.
    Simon, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S267 - S268
  • [45] Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
    Danese, S.
    Neurath, M.
    Kopon, A.
    Zakko, S.
    Simmons, T.
    Fogel, R.
    Maccarone, J.
    Zhan, X.
    Usiskin, K.
    Chitkara, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S5
  • [46] Enteric-release glyceryl trinitrate in active Crohn's disease: a randomized, double-blind, placebo-controlled trial
    Hawkes, ND
    Richardson, C
    Ch'ng, CL
    Green, JT
    Evans, BK
    Williams, J
    Rhodes, P
    Rhodes, J
    Swift, GL
    Thomas, GAO
    Hawthorne, AB
    Kingham, JGC
    Mayberry, JF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 1867 - 1873
  • [47] Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study
    Beigel, Florian
    Teich, Niels
    Howaldt, Stefanie
    Lammert, Frank
    Maul, Jochen
    Breiteneicher, Simone
    Rust, Christian
    Goeke, Burkhard
    Brand, Stephan
    Ochsenkuehn, Thomas
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (11): : 1471 - 1479
  • [48] Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease
    Graham, David Y.
    Naser, Saleh A.
    Borody, Thomas
    Hebzda, Zbigniew
    Sarles, Harry
    Levenson, Scott
    Hardi, Robert
    Arlukowicz, Tomasz
    Svorcan, Petar
    Fathi, Reza
    Bibliowicz, Aida
    Anderson, Patricia
    McLean, Patrick
    Fehrmann, Clara
    Harris, M. Scott
    Zhao, Shuhong
    Kalfus, Ira N.
    ANTIBIOTICS-BASEL, 2024, 13 (08):
  • [49] Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease
    Steed, H.
    Macfarlane, G. T.
    Blackett, K. L.
    Bahrami, B.
    Reynolds, N.
    Walsh, S. V.
    Cummings, J. H.
    Macfarlane, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (07) : 872 - 883
  • [50] Vedolizumab Induction Therapy for Crohn's Disease: Results of Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial
    Sandborn, William
    Sands, Bruce
    Colombel, Jean-Frederic
    Feagan, Brian
    Hanauer, Stephen
    Rutgeerts, Paul
    Lukas, Milan
    Fedorak, Richard
    Lee, Scott
    Bressler, Brian
    Xu, Jing
    Sankoh, Serap
    Stephens, Kristin
    Parikh, Asit
    Fox, Irving
    Milch, Catherine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S624 - S625
12345